by mc | May 14, 2020 | Pharmazz, Press Releases
WILLOWBROOK, Ill., May 14, 2020 /PRNewswire/ — Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, today announced that it has received marketing authorization of...
by mc | Apr 27, 2020 | Pharmazz, Press Releases
WILLOWBROOK, Ill., April 27, 2020 /PRNewswire/ — Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, today announced that sovateltide, an endothelin-B receptor...
by mc | Apr 13, 2020 | News Articles, Pharmazz
Willowbrook, IL (13 April, 2020) /EMPR.com – Centhaquine: An investigational resuscitative agent that is expected to provide hemodynamic stability, improve tissue oxygenation, reduce pulmonary edema, reduce acute respiratory distress syndrome, reduce multiple...
by mc | Apr 9, 2020 | Pharmazz, Press Releases
WILLOWBROOK, Ill., April 9, 2020 /PRNewswire/ — Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, today announced that centhaquine, a drug in final stage of...
by mc | Nov 23, 2019 | Pharmazz, Press Releases
WILLOWBROOK, Ill., Nov. 23, 2019 /PRNewswire/ — Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, today announced the initiation of dosing in its pivotal, phase...
